PRELUDE THERAPEUTICS INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by PRELUDE THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-13UBS ASSET MANAGEMENT AMERICAS INCPrelude Therapeutics Inc00.0%EDGAR
SC 13G/A2024-02-12Vaddi KrishnaPrelude Therapeutics Inc4,908,08611.1%EDGAR
SC 13G/A2024-02-12Flynn James EPrelude Therapeutics Inc4,133,0009.8%EDGAR
SC 13G/A2024-01-10FMR LLCPrelude Therapeutics Inc264,6860.6%EDGAR
SC 13D/A2023-12-13BAKER BROS. ADVISORS LPPrelude Therapeutics Inc10,222,96824.3%EDGAR
SC 13G2023-11-13Flynn James EPrelude Therapeutics Inc3,222,6907.7%EDGAR
SC 13D/A2023-05-24ORBIMED ADVISORS LLCPrelude Therapeutics Inc15,716,64228.6%EDGAR
SC 13D/A2023-05-24BAKER BROS. ADVISORS LPPrelude Therapeutics Inc10,219,08019.5%EDGAR
SC 13G2023-02-13UBS ASSET MANAGEMENT AMERICAS INCPrelude Therapeutics Inc2,507,9925.2%EDGAR
SC 13G/A2023-02-10FMR LLCPrelude Therapeutics Inc4,878,55110.2%EDGAR
SC 13G/A2023-02-10Vaddi KrishnaPrelude Therapeutics Inc4,299,32311.3%EDGAR
SC 13G/A2023-02-09FMR LLCPrelude Therapeutics Inc4,589,5919.6%EDGAR
SC 13G/A2022-02-09FMR LLCPrelude Therapeutics Inc5,938,93212.6%EDGAR
SC 13G/A2022-02-04Vaddi KrishnaPrelude Therapeutics Inc3,618,5539.7%EDGAR
SC 13G2021-02-11Vaddi KrishnaPrelude Therapeutics Inc2,937,77212.6%EDGAR
SC 13G/A2021-02-10FMR LLCPrelude Therapeutics Inc6,351,98113.7%EDGAR
SC 13G2021-02-08FMR LLCPrelude Therapeutics Inc4,209,9639.6%EDGAR
SC 13D/A2021-01-29BAKER BROS. ADVISORS LPPrelude Therapeutics Inc10,126,41728.8%EDGAR
SC 13D/A2021-01-14ORBIMED ADVISORS LLCPrelude Therapeutics Inc14,847,07731.9%EDGAR
SC 13D2020-10-05ORBIMED ADVISORS LLCPrelude Therapeutics Inc14,805,37733.9%EDGAR
External links